Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$234.74 - $275.42 $11,971 - $14,046
-51 Reduced 5.41%
892 $220,000
Q1 2022

Apr 25, 2022

SELL
$243.64 - $270.48 $21,196 - $23,531
-87 Reduced 8.45%
943 $251,000
Q3 2021

Oct 22, 2021

SELL
$232.72 - $256.47 $11,636 - $12,823
-50 Reduced 4.63%
1,030 $253,000
Q2 2021

Jul 20, 2021

SELL
$232.65 - $254.58 $40,713 - $44,551
-175 Reduced 13.94%
1,080 $263,000
Q1 2021

Apr 14, 2021

SELL
$232.09 - $256.88 $94,228 - $104,293
-406 Reduced 24.44%
1,255 $305,000
Q4 2020

Jan 22, 2021

SELL
$221.92 - $245.94 $45,937 - $50,909
-207 Reduced 11.08%
1,661 $416,000
Q3 2020

Oct 27, 2020

SELL
$215.77 - $276.76 $4,315 - $5,535
-20 Reduced 1.06%
1,868 $435,000
Q2 2020

Jul 20, 2020

SELL
$219.9 - $263.41 $21,990 - $26,341
-100 Reduced 5.03%
1,888 $452,000
Q1 2020

Apr 22, 2020

SELL
$195.69 - $279.01 $7,827 - $11,160
-40 Reduced 1.97%
1,988 $457,000
Q4 2019

Jan 29, 2020

SELL
$236.45 - $266.82 $2,364 - $2,668
-10 Reduced 0.49%
2,028 $552,000
Q3 2019

Oct 28, 2019

SELL
$230.58 - $256.08 $9,223 - $10,243
-40 Reduced 1.92%
2,038 $516,000
Q2 2019

Aug 05, 2019

BUY
$217.4 - $246.08 $5,435 - $6,152
25 Added 1.22%
2,078 $524,000
Q4 2018

Jan 25, 2019

SELL
$204.73 - $257.93 $204 - $257
-1 Reduced 0.05%
2,053 $463,000
Q2 2018

Dec 12, 2018

SELL
$208.1 - $233.85 $11,445 - $12,861
-55 Reduced 2.61%
2,054 $492,000
Q1 2018

Dec 21, 2018

BUY
$205.46 - $240.27 $18,080 - $21,143
88 Added 4.35%
2,109 $457,000
Q4 2017

Dec 26, 2018

BUY
$189.0 - $222.64 $381,969 - $449,955
2,021
2,021 $433,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Plimoth Trust CO LLC Portfolio

Follow Plimoth Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plimoth Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plimoth Trust CO LLC with notifications on news.